NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
31 hedge funds and large institutions have $6.91M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$108K
Puts
$73K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$195K | |
| 3 | +$20.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.69K |
| 5 |
Morgan Stanley
New York
|
+$658 |
Top Sellers
| 1 | -$290K | |
| 2 | -$244K | |
| 3 | -$37.6K | |
| 4 |
Millennium Management
New York
|
-$12.7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$10K |